Published in Neuromolecular Med on October 02, 2011
Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol (2014) 1.50
Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc (2012) 1.12
Renalase prevents AKI independent of amine oxidase activity. J Am Soc Nephrol (2014) 1.07
Renalase's expression and distribution in renal tissue and cells. PLoS One (2012) 1.04
Identification of a receptor for extracellular renalase. PLoS One (2015) 0.93
Renalase: its role as a cytokine, and an update on its association with type 1 diabetes and ischemic stroke. Curr Opin Nephrol Hypertens (2014) 0.90
Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy. J Cell Mol Med (2016) 0.80
Association of Renalase SNPs rs2296545 and rs2576178 with the Risk of Hypertension: A Meta-Analysis. PLoS One (2016) 0.79
Serum renalase is related to catecholamine levels and renal function. Clin Exp Nephrol (2014) 0.79
Renalase Gene rs2576178 Polymorphism in Hemodialysis Patients: Study in Bosnia and Herzegovina. Med Arch (2016) 0.79
The association study on renalase polymorphism and hypertension: a meta-analysis. Int J Clin Exp Med (2015) 0.78
Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis. Clin Interv Aging (2016) 0.78
Rs10887800 renalase gene polymorphism is associated with an increased risk of coronary artery disease in hemodialyzed patients. Int Urol Nephrol (2016) 0.77
Effect of salt intake and potassium supplementation on serum renalase levels in Chinese adults: a randomized trial. Medicine (Baltimore) (2014) 0.76
Intramyocardial Injection of siRNAs Can Efficiently Establish Myocardial Tissue-Specific Renalase Knockdown Mouse Model. Biomed Res Int (2016) 0.75
Renalase, a new secretory enzyme: Its role in hypertensive-ischemic cardiovascular diseases. Med Sci Monit (2014) 0.75
Renalase as a Novel Biomarker for Evaluating the Severity of Hepatic Ischemia-Reperfusion Injury. Oxid Med Cell Longev (2016) 0.75
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53
Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (2001) 4.62
A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet (2009) 4.28
DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet (1987) 4.09
The genetic dissection of essential hypertension. Nat Rev Genet (2006) 2.77
Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest (2005) 2.75
Renalase deficiency aggravates ischemic myocardial damage. Kidney Int (2010) 2.10
Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol (1996) 1.94
Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol (2004) 1.73
Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol (2000) 1.68
Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med (Berl) (2007) 1.58
Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation (2008) 1.54
Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol (2010) 1.27
Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun (2011) 1.18
Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens (2008) 1.11
Role of renalase in the regulation of blood pressure and the renal dopamine system. Curr Opin Nephrol Hypertens (2011) 1.07
Renalase deficiency in heart failure model of rats--a potential mechanism underlying circulating norepinephrine accumulation. PLoS One (2011) 1.07
The genetics of ischaemic stroke. J Intern Med (2010) 1.01
Renalase is a novel renal hormone that regulates cardiovascular function. J Am Soc Hypertens (2010) 0.99
The genetic basis of essential hypertension. Acta Cardiol (2007) 0.86
The etiology of hypertension in the metabolic syndrome part two: the gene-environment interaction. Curr Vasc Pharmacol (2006) 0.83
Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention. Am J Med (2007) 0.82
Recommendations for the treatment of hypertension in patients with DM: critical evaluation based on clinical trials. Curr Clin Pharmacol (2006) 0.79
Hypertension and the older diabetic. Clin Geriatr Med (2008) 0.78
Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant (2011) 1.01
Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant (2005) 0.96
Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol (2009) 0.94
Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol (2003) 0.94
TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol (2007) 0.93
Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant (2004) 0.88
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Cytokine (2008) 0.87
The investigation of Staphylococcus aureus and coagulase-negative staphylococci nasal carriage among patients undergoing haemodialysis. Microbiol Res (2005) 0.86
Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract (2011) 0.85
Chemotactic cytokine receptor 5 gene polymorphism: relevance to microvascular complications in type 2 diabetes. Cytokine (2012) 0.85
Effects of vitamin D3 on selected biochemical parameters of nutritional status, inflammation, and cardiovascular disease in patients undergoing long-term hemodialysis. Pol Arch Med Wewn (2010) 0.85
Endothelial nitric oxide synthase gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head. Int Orthop (2013) 0.83
Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. Clin Sci (Lond) (2009) 0.83
Effect of haemodialysis on regional and transmural inhomogeneities of the ventricular repolarisation phase. Nephron Clin Pract (2005) 0.82
Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities. Clin Biochem (2010) 0.82
Nutrition and hydration status improve with exercise training using stationary cycling during hemodialysis (HD) in patients with end-stage renal disease (ESRD). Ann Univ Mariae Curie Sklodowska Med (2002) 0.82
Aortic stiffness and valvular calcifications in patients with end-stage renal disease. Pol Arch Med Wewn (2008) 0.81
Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing haemodialysis treatment. New Microbiol (2007) 0.80
Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T. Nephrol Dial Transplant (2008) 0.80
Association of the human bradykinin B2 receptor gene with chronic renal failure. Mol Diagn (2004) 0.80
[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. Pol Arch Med Wewn (2002) 0.79
Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients. Ren Fail (2007) 0.79
Influence of the hepatocellular damage on the clinical usefulness of biochemical markers of bone metabolism and parathormon in haemodialysed patients. Med Sci Monit (2002) 0.79
Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease. Nephron (2002) 0.79
The intercellular adhesion molecule-1 (ICAM-1) gene polymorphism K469E in end-stage renal disease patients with cardiovascular disease. Hum Immunol (2012) 0.78
Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland. BMC Musculoskelet Disord (2013) 0.78
Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients. Clin Immunol (2009) 0.78
Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure. Clin Chem Lab Med (2006) 0.78
Effect of haemodialysis on signal-averaged electrocardiogram P-wave parameters. Nephrol Dial Transplant (2005) 0.78
Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant (2004) 0.78
[Femoral neck fractures in hemodialysis patients]. Przegl Lek (2003) 0.78
Concentrations of branched amino acids: isoleucine, valine, leucine in serum of hemodialysis patients during one-year observation. Ann Univ Mariae Curie Sklodowska Med (2002) 0.77
Transcription factor 7-like 2 (TCF7L2) gene polymorphism and clinical phenotype in end-stage renal disease patients. Mol Biol Rep (2014) 0.77
A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients. Ren Fail (2006) 0.77
Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes. Kidney Blood Press Res (2006) 0.77
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in Poland: further evidence for the changing epidemiology of MRSA. New Microbiol (2008) 0.77
Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy. Ren Fail (2004) 0.77
[Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients]. Pol Arch Med Wewn (2003) 0.76
[Analysis of some risk factors of coronary artery calcification in peritoneal dialysis patients]. Pol Arch Med Wewn (2006) 0.76
Expression of soluble HLA-G in multiple myeloma patients and patients with renal failure. Leuk Res (2012) 0.76
Phosphate Kinetics in Hemodialysis: Application of Delayed Pseudo One-Compartment Model. Blood Purif (2016) 0.75
Changes of extracellular volumes measured by whole and segmental bioimpedance analysis during hemodialysis in end-stage renal disease (ESRD) patients. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Factors producing increase of QRS complex amplitude during hemodialysis]. Przegl Lek (2005) 0.75
Effect of acetate and bicarbonate dialysate on whole body bioimpedance (BIS) and segmental (thoracic) bioimpedance in hemodialysed (HD) patients. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Urologic complications as a reason of recurrent urinary tract infections in patients after renal transplantation]. Wiad Lek (2004) 0.75
The -308 promoter polymorphism in the tumour necrosis factor gene in patients with lichen planus. Acta Derm Venereol (2005) 0.75
[Secondary amyloidosis connected with neoplasma of urinary bladder and acquired disorders of blood coagulation. Case report]. Pol Arch Med Wewn (2006) 0.75
Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study. Transpl Int (2007) 0.75
Care provided for hemodialysis patients in selected dialysis centres of the Lublin region. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Whole body versus segmental bioimpedance measurements (BIS) of electrical resistance (Re) and extracellular volume (ECV) for assessment of dry weight in end-stage renal patients treated by hemodialysis]. Przegl Lek (2004) 0.75
[Influence of hemodialysis on the homogenicity of repolarization phase of action potential of myocardium]. Pol Merkur Lekarski (2002) 0.75
[Can human recombinant erythropoietin (rHuEPO) be considered as cardiological medicine?]. Przegl Lek (2005) 0.75
Sialic acid content in erythrocyte membranes of patients on chronic hemodialysis. Pol Arch Med Wewn (2009) 0.75
[Factors influencing signal-averaged ECG parameters in hemodialysis patients]. Przegl Lek (2005) 0.75
Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol Diagn Ther (2007) 0.75
[Hemolytic uremic syndrome]. Pol Arch Med Wewn (2005) 0.75
Comparison between some anthropometric measurements in adequately treated peritoneal dialysis and hemodialysis patients. Ann Univ Mariae Curie Sklodowska Med (2004) 0.75
How are hemodialysis patients treated in the Lublin region--based on the selected issues of diagnosis and therapy. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[28-year-old woman with Goodpasture's syndrome and nonspecific colitis]. Pol Arch Med Wewn (2004) 0.75
Hypercalcemia in patients treated with CAPD. Ann Univ Mariae Curie Sklodowska Med (2004) 0.75
[Prevalence of depressive disorders in patients with end-stage renal failure]. Psychiatr Pol (2011) 0.75
[Pseudo-Bartter syndrome--2 cases]. Przegl Lek (2010) 0.75
Comparison of lipid and lipoprotein profiles in long-term chronic ambulatory peritoneal dialysis (CAPD) in elderly patients with chronic renal failure (CRF). Int Urol Nephrol (2002) 0.75
Adequacy of hemodialysis. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R]. Pol Merkur Lekarski (2014) 0.75
Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients. Hum Immunol (2010) 0.75
[Are there relationship between Helicobacter pylori infection and gastrin levels in long term hemodialysed patients?]. Przegl Lek (2002) 0.75
[Changes in selected parameters of bone turnover resulting from use of different calcium concentrations in dialysate of patients treated with CAPD]. Pol Arch Med Wewn (2004) 0.75
Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis. Mol Diagn (2003) 0.75
[Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age]. Pol Arch Med Wewn (2005) 0.75
[Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report]. Przegl Lek (2007) 0.75
[Polymorphism of angiotensin II type 1 receptor in terminal renal failure]. Pol Merkur Lekarski (2002) 0.75
[Some aspects of homocysteine metabolism in hemodialysis patients]. Pol Arch Med Wewn (2002) 0.75
Effect of prostaglandin E1 on peritoneal membrane transport in CAPD-treated diabetic patients. Perit Dial Int (2008) 0.75
[Clinical analysis of CAPD-treated patients without anemia]. Wiad Lek (2003) 0.75
[Acute cardiac failure secondary to brachiocephalic arteriovenous fistula in patient on chronic haemodialysis]. Pol Arch Med Wewn (2004) 0.75
Comparison of prescribed and delivered doses of dialysis using anthropometrically and bioelectrically measured patient volumes. Med Sci Monit (2003) 0.75